Katie Garman, MD, is an Assistant Professor in the Department of Medicine and the IGSP. She received her medical degree from Duke and completed both her internal medicine residency and gastroenterology fellowship at Duke. Dr. Garman's main research interest is the pathogenesis of gastrointestinal malignancy, and the detection of pre-malignant disease. She is working on molecular pathways in Barrett's esophagus, a precursor of esophageal adenocarcinoma. Her overall goal is to apply work from the bench to risk stratification of patients with pre-malignant disease to improve cancer screening and surveillance in the gastrointestinal tract.
Peery AF, Hoppo T, Garman KS, Dellon ES, Daugherty N, Bream S, Sanz AF, Davison J, Spacek M, Connors D, Faulx AL, Chak A, Luketich JD, Shaheen NJ, Jobe BA, , Gastrointest Endosc. 2012 Mar 15;. Abstract
Garman KS, Orlando RC, Chen XL, Am J Physiol Gastrointest Liver Physiol. 2012 Mar 15;. Abstract
Garman KS, Shaheen NJ, Curr Gastroenterol Rep. 2011 Jun;13(3):226-39. Abstract
Tempelhof MW, Garman KS, Langman MK, Adams MB, Inform Prim Care. 2009;17(2):87-94. Abstract
Echols MR, Garman KS, Lyles KW, N Engl J Med. 2007 Mar 22;356(12):1272; author reply 1273-4. Abstract
© 2004-2012, Duke Institute for Genome Sciences & Policy. Duke University | Duke Medicine | Interdisciplinary Studies at Duke